A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna

Detalles Bibliográficos
Autor principal: Siranosian, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549574/
https://www.ncbi.nlm.nih.gov/pubmed/36285021
http://dx.doi.org/10.1017/cts.2022.443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549574/
https://www.ncbi.nlm.nih.gov/pubmed/36285021
http://dx.doi.org/10.1017/cts.2022.443

Ejemplares similares